Emcure Pharmaceuticals Limited
NSE: EMCURE | Information Technology
Market Fundamentals
Stock Intelligence & News
Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange regarding Acquisition (including agreement to acquire) |SUBJECT: Acquisition (including agreement to acquire)-XBRL
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange regarding Acquisition (including agreement to acquire) |SUBJECT: Acquisition (including agreement to acquire)-XBRL
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition |SUBJECT: Acquisition
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 June
Indian equity benchmarks opened higher today, driven by gains in Asian markets and easing crude oil prices. The Nifty 50 rose 0.43%, and market breadth remained positive with 15 out of 16 major indices in the green, showcasing investor confidence amid improving global sentiment.
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange regarding Allotment of 20600 Shares. |SUBJECT: ESOP/ESOS/ESPS
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.
Read Full Analysis →PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 70000 securities pursuant to ESOP/ESPS at its meeting held on May 27, 2026 |SUBJECT: Allotment of Securities
Read Full Analysis →Stocks to watch: ICICI Bank, HFCL, Dr Reddy’s, Adani Ports, Uno Minda among key movers
Shares of ICICI Bank, RBL Bank, Coal India, PFC, REC, Adani Ports, HFCL, Hindustan Copper, Uno Minda and pharma companies including Dr Reddy’s, Aurobindo Pharma and Emcure Pharma will remain in focus amid deals, expansion plans and regulatory developments.
Read Full Analysis →Get instant alerts when EMCURE breaks news
Join investors who track Emcure Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for EMCURE?
EMCURE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Emcure Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding EMCURE to your custom watchlist.